COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND METAANALYSIS

Authors
Category Systematic review
ConferenceEHA2023 Hybrid Congress
Year 2023
This article has no abstract
Epistemonikos ID: 2fe768273efe6be1c4fa4a1653837d14dca74e92
First added on: Apr 22, 2026